To the Editor We greatly appreciated the article by Wu et al,1 which showed the independent association between long-term hypertension, long-term administration of β-blockers, and incident psoriasis in a large prospective cohort. However, although the study presented new evidence of the association, no management advice was proposed. How should patients with hypertension, who have the propensity to have psoriasis, be treated?
Huang B, Zhang R, Chen M. Balancing the Cardiovascular Risk and Dermatologic Hazard in Patients With Hypertension. JAMA Dermatol. 2014;150(12):1372-1373. doi:10.1001/jamadermatol.2014.2551